Novartis Cosentyx® PMR data in New England Journal of Medicine showed sustained remission vs placebo in twice as many patients Novartis (Press Release) 16:38 Wed, 03 Jun
Celltrion files for approval of Cosentyx biosimilar, CT-P55, in Canada Korea Biomedical Review 07:57 Mon, 01 Jun